ALKBH1 and glioblastoma: The results presented that the genetic alteration rates of ALKBH1-8/FTO in GBM tumor samples were 2.9%, 1.9%, 1.7%, 10%, 1.5%, 2.4%, 2.2%, 1% and 3%, respectively (Figure 4A).